NEW YORK, April 14, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Dick’s Sporting Goods, Inc. (NYSE: DKS) between May 25, 2022 and August 21, 2023, both dates inclusive (the “Class Period”), of the important April 22, 2024

NEW YORK, April 14, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of Amplitude, Inc. (NASDAQ: AMPL) between September 21, 2021 and February 16, 2022, both dates inclusive (the “Class Period”), of the important April 15, 2024 lead plaintiff

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of iRobot Corporation (NASDAQ: IRBT) between August 5, 2022 and January 26, 2024, both dates inclusive (the “Class Period”), of the important May 7, 2024 lead plaintiff deadline.

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innoviz Technologies Ltd. (NASDAQ: INVZ, INVZW) between April 21, 2021 and February 28, 2023, both dates inclusive (the “Class Period”), of the important May 14, 2024 lead

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and December 8, 2023, both dates inclusive (the “Class Period”), of the important May 28, 2024 lead

NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Autodesk, Inc. (NASDAQ: ADSK) resulting from allegations that Autodesk may have issued materially misleading business information to the investing public.

Nyxoah Appoints Dr. Maurits S. Boon, MD as Chief Medical Officer Mont-Saint-Guibert, Belgium – April 11, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea

NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Banco Santander, S.A. (NYSE: SAN) resulting from allegations that Santander may have issued materially misleading business information to the investing public.

NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Equinix Inc. (NASDAQ: EQIX) resulting from allegations that Equinix may have issued materially misleading business information to the investing public. SO